Personalized Transcranial Direct Current Stimulation in Stroke Recovery
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The Methodist Hospital Research Institute
- Study ID
- NCT06286800
- Status
- Recruiting
Conditions
- Chronic Stroke
- Hemorrhage Brain
- Ischemic Stroke
- Stroke
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Transcranial direct current stimulation (tDCS) with OT — DEVICEWeak direct current (0.5-2 mA) will be delivered for up to 20 minutes through surface electrodes which will be positioned using the ptDCS montage. The current will be increased and decreased ramp-like at the beginning and end of the 20-minute stimulation to lessen the itchy/numb skin sensation and decrease the likelihood of an innocuous phosphene-like visual phenomenon. The stimulation will be delivered during the first 20 minutes of occupational therapy targeted to the more affected upper extremity.
- Sham tDCS with OT — DEVICESame procedure and montage as with the active stimulation but the current will be increased then decreased ramp-like and switched off after 20 seconds instead of the 20 minutes to elicit the same cutaneous sensation as the other stimulation conditions. \[69\] This short length of stimulation is documented to elicit sensations comparable to those of real stimulation. With this procedure, subjects were unable to differentiate between tDCS and sham stimulation in our and other previous studies.
Study Details
The central objective of this application is to explore the neural substrate of personalized tDCS (ptDCS) and to determine whether the paradigm for each stroke patient can predict the amount of sustained clinical improvement through increased connectivity as measured by a biomarker of plasticity.
Key Dates
- Start date
- Dec 18, 2024
- Status verified
- Feb 2026
- Primary completion
- Mar 14, 2027
- Completion
- Sep 14, 2027
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Personalized Transcranial direct current stimulation (ptDCS)TDCS is a noninvasive form of cortical stimulation that uses a battery-powered device. \[67\] Weak current (0.5-2 mA) will be delivered for up to 20 minutes through surface electrodes which will be positioned using the montage identified as the best in the individual stroke patient during our initial testing session during OT targeting the affected arm.
- Placebo Comparator: Sham tDCSSame OT procedure and montage as with the active stimulation but the current will be increased then decreased ramp-like and switched off after 20 seconds instead of the 20 minutes to elicit the same cutaneous sensation as the other stimulation conditions.
Primary Outcome Measure
fMRI functional connectivity biomarker [ Time Frame: baseline and 4 weeks ]
Central Contacts
- Neha Sudarshan, MD9082277275
- Timea Hodics, MD281-381-1728
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Houston Methodist Hospital | Houston | Texas | 77030 |
Find similar trials in Houston, TX
By condition
By specialty
By research site
Related Studies
- Human-Machine System for the H2 Lower Limb ExoskeletonRecruiting · University of Houston · Houston, Texas
- Get With the Guidelines-Stroke RegistryRecruiting · American Heart Association · Dallas, Texas
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With StressPHASE4 · Recruiting · Population Health Research Institute · Los Angeles, California